These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26087295)

  • 1. Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults.
    Kennedy RB; Tosh PK; Goergen KM; Grill DE; Oberg AL; Poland GA
    Vaccine; 2015 Jul; 33(31):3682-8. PubMed ID: 26087295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
    Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.
    Moroz E; Albrecht RA; Aden B; Beeder AB; Yuan J; García-Sastre A; Edlin BR; Salvatore M
    Vaccine; 2016 Mar; 34(11):1363-9. PubMed ID: 26859239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population--a practical observation.
    Sun F; Zhang Y; Tian D; Zheng M; Liu L; Zhang R; Dai Z; Chen J; Li T; Lu H
    Vaccine; 2011 Sep; 29(38):6527-31. PubMed ID: 21767595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
    Tremblay CL; Rouleau D; Fortin C; Toma E; Sylla M; Cyr L; Cote S; Baz M; Sampalis J; Trautman L; Sékaly RP; Boivin G
    Vaccine; 2011 Feb; 29(7):1359-63. PubMed ID: 21185423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
    Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses after inactivated influenza vaccine in young children.
    Wright PF; Sannella E; Shi JR; Zhu Y; Ikizler MR; Edwards KM
    Pediatr Infect Dis J; 2008 Nov; 27(11):1004-8. PubMed ID: 18833023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signatures associated with adaptive humoral immunity following seasonal influenza A/H1N1 vaccination.
    Ovsyannikova IG; Salk HM; Kennedy RB; Haralambieva IH; Zimmermann MT; Grill DE; Oberg AL; Poland GA
    Genes Immun; 2016 Dec; 17(7):371-379. PubMed ID: 27534615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
    Kumagai T; Nakayama T; Okuno Y; Kase T; Nishimura N; Ozaki T; Miyata A; Suzuki E; Okafuji T; Okafuji T; Ochiai H; Nagata N; Tsutsumi H; Okamatsu M; Sakoda Y; Kida H; Ihara T
    Viral Immunol; 2014 Oct; 27(8):368-74. PubMed ID: 25211638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
    N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of inactivated subunit adsorbed monovalent vaccine against influenza A/California/7/2009 (H1N1) strain].
    Zverev VV; Kostinov MP; Mikhailova NA; Zhirova SN; Mironov AN; Terkacheva OA; Romanova AA; Cherdantsev AP
    Vopr Virusol; 2011; 56(3):20-3. PubMed ID: 21786622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).
    Weinberg A; Muresan P; Fenton T; Richardson K; Dominguez T; Bloom A; Petzold E; Anthony P; Cunningham CK; Spector SA; Nachman S; Siberry GK; Handelsman E; Flynn PM;
    Hum Vaccin Immunother; 2013 May; 9(5):957-68. PubMed ID: 23370281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.
    Kennedy RB; Simon WL; Gibson MJ; Goergen KM; Grill DE; Oberg AL; Poland GA
    Immunology; 2016 Jul; 148(3):266-75. PubMed ID: 27188667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Vaccine; 2015 Aug; 33(36):4565-71. PubMed ID: 26187260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.